<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Surg</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Surg</journal-id>
      <journal-title-group>
        <journal-title>BMC Surgery</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2482</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25884651</article-id>
      <article-id pub-id-type="pmc">4359764</article-id>
      <article-id pub-id-type="publisher-id">7</article-id>
      <article-id pub-id-type="doi">10.1186/s12893-015-0007-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Choroid vascular occlusion and ischemic optic neuropathy after facial calcium hydroxyapatite injection- a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Chou</surname>
            <given-names>Chien-Chih</given-names>
          </name>
          <address>
            <email>doctorccc@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Hsin-Han</given-names>
          </name>
          <address>
            <email>D13749@mail.cmuh.org.t</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsai</surname>
            <given-names>Yi-Yu</given-names>
          </name>
          <address>
            <email>D6443@mail.cmuh.org.t</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>You-Ling</given-names>
          </name>
          <address>
            <email>yulingmeet@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lin</surname>
            <given-names>Hui-Ju</given-names>
          </name>
          <address>
            <email>irisluu2396@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff3"/>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Ophthalmology, China Medical University Hospital, No. 2 Yuh Der Road, Taichung, 404 Taiwan </aff>
        <aff id="Aff2"><label/>Department of Plastic and Reconstructive Surgery, China Medical University Hospital, Taichung, Taiwan </aff>
        <aff id="Aff3"><label/>Department of Medical Research, China Medical University Hospital, Taichung, Taiwan </aff>
        <aff id="Aff4"><label/>School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>3</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>8</day>
        <month>3</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>21</elocation-id>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>11</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>2</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Chou et al.; licensee BioMed Central. 2015</copyright-statement>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>We reported a case of sudden monocular vision loss after calcium hydroxyapatite (CaHA) injection into the nasal tip and dorsum with detailed retina images.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A healthy, 35-year-old woman received CaHA filler injection for nose augmentation. Ten minutes after the procedure, she developed nausea, vomiting, headache, ptosis, and left periorbital pain. After 30&#xA0;minutes, she complained of progressively blurring vision in the left eye. The best-corrected visual acuity (BCVA) in her left eye was 30&#xA0;cm ahead of hand motion. Left exotropia was noted in primary gaze. Limitations in adduction, supraduction, and infraduction of the left eye were also observed. Slit lamp examination of the left eye revealed a pink conjunctiva, a clear cornea, a mild anterior chamber reaction, a sluggish papillary light reflex, and a semi-dilated pupil. A positive relative afferent pupillary defect was observed in the left eye. Fundus examination revealed optic disc edema and some linear whitish opacity over the superior and temporal sites in the left eye, suggesting multiple CaHA emboli in the choroid vessels.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Although the majority of adverse reactions are mild and transient, surgeons should be alert about extremely rare serious adverse events such as visual loss.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Calcium hydroxyapatite</kwd>
        <kwd>Nose augmentation</kwd>
        <kwd>Choroid vascular occlusion</kwd>
        <kwd>Ischemic optic neuropathy</kwd>
        <kwd>Vision loss</kwd>
        <kwd>Filler</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Facial plastic surgery reverses the signs of aging. Injectable facial fillers are effective in ameliorating certain signs of aging [<xref ref-type="bibr" rid="CR1">1</xref>], and calcium hydroxyapatite (CaHA) is one of the most commonly used fillers for this purpose [<xref ref-type="bibr" rid="CR2">2</xref>]. Serious adverse events are rarely observed, and the majority of adverse reactions are mild and transient [<xref ref-type="bibr" rid="CR3">3</xref>]. Here we report the case of a 35-year-old woman who developed sudden monocular vision loss after CaHA injection into the nasal tip and dorsum.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A healthy, 35-year-old woman without any history of ocular and systemic disease received CaHA filler injections (RADIESSE&#xAE; 1.5&#xA0;ml) for cosmetic nose augmentation. Multiple injections along midline of the nasal dorsum from nasal tip to glabella were performed under local anesthesia. Ten minutes after the procedure, she developed nausea, vomiting, headache, ptosis, and left periorbital pain. After 30&#xA0;minutes, she complained of progressively blurring vision in the left eye. The best-corrected visual acuity (BCVA) in her left eye was 30&#xA0;cm ahead of hand motion. Skin necrosis developed over the nasal dorsum, glabellar region, and left forehead (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>a). Left exotropia was noted in primary gaze. Limitations in adduction, supraduction, and infraduction of the left eye were also observed (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>b). Slit lamp examination of the left eye revealed a pink conjunctiva, a clear cornea, a mild anterior chamber reaction, a sluggish pupillary light reflex, and a semi-dilated pupil. A positive relative afferent pupillary defect was observed in the left eye. The intraocular pressure was normal in both eyes. Fundus examination revealed optic disc edema and some linear whitish opacities over the superior and temporal sites in the left eye, suggesting multiple CaHA emboli in the choroid vessels (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>a,b). Optical coherence tomography (OCT) revealed disc edema without macular edema in the left eye (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>c). Fluorescein angiography revealed neither delayed filling nor hypofluroescence in the left eye. Visual field testing revealed an inferior altitudinal visual field defect in the left eye. Measurement of the visual evoked potential (VEP) showed a decreased amplitude and marked delay in the appearance of peaks. Electroretinography (ERG) showed a normal waveform. All examinations were normal in the right eye. Orbital computed tomography (CT) demonstrated high-density deposits in the nose region and left medial orbital cavity (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). No evident lesion was noted on brain magnetic resonance imaging (MRI).<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Skin necrosis developed at nasal dorsum, glabellar region, and left forehead (a).</bold> Left exotropia was noted in primary gaze, and limitations on adduction, supraduction, and infraduction in left eye were also noted <bold>(b)</bold>.</p></caption><graphic xlink:href="12893_2015_7_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Fundus examination revealed optic disc edema and some linear whitish opacities over the superior and temporal sites in the left eye, suggesting multiple CaHA emboli in the choroid vessels (a).</bold> No macular edema in left eye was revealed on fundus examination <bold>(b)</bold>, or OCT <bold>(c)</bold>.</p></caption><graphic xlink:href="12893_2015_7_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>Orbital CT demonstrates multiple radiopaque spots in the subcutaneous layer of medial aspect of left periorbital region, suggesting CaHA deposition.</bold>
</p></caption><graphic xlink:href="12893_2015_7_Fig3_HTML" id="MO3"/></fig></p>
      <p>Alprostadil and dextran were administered for improving blood supply. Moreover, ten sessions of hyperbaric oxygen therapy were administered. One month later, the visual acuity in her left eye improved to 6/60. A pale disc was observed, with persistent plaque occlusions in the choroid vessels.</p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>There are few reports of vision loss following facial injection of autologous fat or hyaluronic acid [<xref ref-type="bibr" rid="CR4">4</xref>-<xref ref-type="bibr" rid="CR6">6</xref>]. In a previous study, Lazzeri et al. [<xref ref-type="bibr" rid="CR7">7</xref>] reported 32 cases of blindness caused by iatrogenic retinal embolism after cosmetic facial filler injections, while Park et al. [<xref ref-type="bibr" rid="CR8">8</xref>] reported 12 cases of retinal artery occlusion caused by cosmetic facial filler injections. Furthermore, Park et al. [<xref ref-type="bibr" rid="CR9">9</xref>] showed the clinical and angiographic features of occlusion of the ophthalmic artery and its branches caused by cosmetic facial filler injections. In these 44 cases, only one was attributed to CaHA, and no CaHA emboli were clearly observed on fundus photography.</p>
      <p>Sung et al. [<xref ref-type="bibr" rid="CR10">10</xref>] postulated that emboli may move in a retrograde fashion to the ophthalmic artery under a high injection pressure. In the present case, multiple emboli localized on the choroidal layer without retinal vessel occlusion, resulting in normal ERG waveform. However, poor vision, a positive RAPD sign, and a pale, swollen disc were present. Visual field testing showed an inferior altitudinal visual field defect. We postulate that the CaHA emboli migrated via the dorsonasal artery back to the main ciliary arteries and occluded the short posterior ciliary arteries, which supply the superior nasal choroid and the optic nerve. Subsequently, ischemic optic neuropathy developed and caused poor vision, a positive RAPD sign, a pale, swollen disc, and an abnormal waveform on VEP. Furthermore, we first postulated that the occluded vessel was Haller&#x2019;s layer because the distribution pattern of affected vessels was consistent with the Haller&#x2019;s layer distribution pattern.</p>
      <p>The emboli moved back to branches supplying the oculomotor nerve, causing blepheroptosis and ophtalmoplegia. This is compatible with the CT findings (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). The ptosis and limitation in supraduction subsided gradually. We postulate that the superior division of the oculomotor nerve innervating the levator and superior rectus muscles recovered early.</p>
      <p>In previously reported cases of CaHA injections and in this case, there was no cerebral infarction, which is more frequently observed after autologous fat injections [<xref ref-type="bibr" rid="CR9">9</xref>]. This may be related to properties of the filler material, such as molecular weight or size.</p>
      <p>To decrease the risk of intravascular injection and retrograde occlusion, Park et al. suggested slow injection in a fractionated dose and the use of a blunt cannula [<xref ref-type="bibr" rid="CR9">9</xref>]. We suggest the use of a mixture of CaHA and epinephrine because epinephrine leads to vasoconstriction and thus decreases the possibility of intravascular injection. Soft tissue can be dissected to create a subcutaneous space for subsequent filler injection. Furthermore, an injection device with a valve that can relieve excessive injection pressure can be designed for this purpose.</p>
      <p>Injectable facial fillers have become increasingly popular these days. Although the majority of adverse reactions are mild and transient, surgeons should be alert about extremely rare serious adverse events such as visual loss. Most cases of blindness are caused by autologous fat and hyaluronic acid injections. To the best of our knowledge, localized choroid vascular occlusion, ischemic optic neuropathy, and cranial nerve III palsy without evidence of compromised retinal or choroidal circulation after CaHA injection have not been reported.</p>
    </sec>
    <sec id="Sec4" sec-type="conclusion">
      <title>Conclusion</title>
      <p>In conclusion, we reported a case of sudden monocular vision loss after CaHA filler injection into the nasal tip and dorsum. CaHA emboli were clearly observed in this case, providing direct evidence to prove the mechanism underlying retrograde occlusion after facial filler injection.</p>
      <sec id="Sec5">
        <title>Consent statement</title>
        <p>Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.</p>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>All authors certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers&#x2019; bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>CCC and YLL participated in the drafted the manuscript. HJL, HHC, and YYT, participated in the design of the study and helped to draft the manuscript. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jacovella</surname>
              <given-names>PF</given-names>
            </name>
          </person-group>
          <article-title>Use of calcium hydroxylapatite (Radiesse&#xAE;) for facial augmentation</article-title>
          <source>Clin Interv Aging</source>
          <year>2008</year>
          <volume>3</volume>
          <issue>1</issue>
          <fpage>161</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">18488886</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jurado</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Olivetti</surname>
              <given-names>IP</given-names>
            </name>
            <name>
              <surname>Arroyo</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>de Oliveira</surname>
              <given-names>IH</given-names>
            </name>
          </person-group>
          <article-title>Innovations in minimally invasive facial treatments</article-title>
          <source>Facial Plast Surg</source>
          <year>2013</year>
          <volume>29</volume>
          <issue>3</issue>
          <fpage>154</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1055/s-0033-1347004</pub-id>
          <pub-id pub-id-type="pmid">23761118</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Funt</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pavicic</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Dermal fillers in aesthetics: an overview of adverse events and treatment approaches</article-title>
          <source>Clin Cosmet Investig Dermatol</source>
          <year>2013</year>
          <volume>6</volume>
          <fpage>295</fpage>
          <lpage>316</lpage>
          <pub-id pub-id-type="pmid">24363560</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dreizen</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Framm</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Sudden visual loss after autulogous fat injection into the glabellar area</article-title>
          <source>Am J Ophthalmol</source>
          <year>1989</year>
          <volume>107</volume>
          <fpage>85</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1016/0002-9394(89)90823-4</pub-id>
          <pub-id pub-id-type="pmid">2912125</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Danesh-Meyer</surname>
              <given-names>HV</given-names>
            </name>
            <name>
              <surname>Savino</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Sergott</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Case reports and small case series: ocular and cerebral ischemia following facial injection of autologous fat</article-title>
          <source>Arch Ophthalmol</source>
          <year>2011</year>
          <volume>119</volume>
          <fpage>777</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">11346413</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peter</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mennel</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Retinal branch artery occlusion following injection of hyaluronic acid (Restylane)</article-title>
          <source>Clin Experiment Ophthalmol</source>
          <year>2006</year>
          <volume>34</volume>
          <fpage>363</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1442-9071.2006.01224.x</pub-id>
          <pub-id pub-id-type="pmid">16764658</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lazzeri</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Agostini</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Figus</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nardi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pantaloni</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lazzeri</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Blindness following cosmetic injections of the face</article-title>
          <source>Plast Reconstr Surg</source>
          <year>2012</year>
          <volume>129</volume>
          <issue>4</issue>
          <fpage>995</fpage>
          <lpage>1012</lpage>
          <pub-id pub-id-type="doi">10.1097/PRS.0b013e3182442363</pub-id>
          <pub-id pub-id-type="pmid">22456369</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Woo</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Huh</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>OK</given-names>
            </name>
          </person-group>
          <article-title>Iatrogenic retinal artery occlusion caused by cosmetic facial filler injections</article-title>
          <source>Am Ophthalmol</source>
          <year>2012</year>
          <volume>154</volume>
          <issue>4</issue>
          <fpage>653</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajo.2012.04.019</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YK</given-names>
            </name>
            <name>
              <surname>Woo</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>WK</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>KS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Iatrogenic retinal artery occlusion caused by cosmetic facial filler injections: a national survey by the Korean Retina Society</article-title>
          <source>JAMA Ophthalmol</source>
          <year>2014</year>
          <volume>132</volume>
          <issue>6</issue>
          <fpage>714</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="doi">10.1001/jamaophthalmol.2013.8204</pub-id>
          <pub-id pub-id-type="pmid">24676334</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sung</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Woo</surname>
              <given-names>KI</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YD</given-names>
            </name>
          </person-group>
          <article-title>Ocular ischemia and ischemic oculomotor nerve palsy after vascular embolization of injectable calcium hydroxylapatite filler</article-title>
          <source>Ophthal Plast Reconstr Surg</source>
          <year>2010</year>
          <volume>26</volume>
          <fpage>289</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="doi">10.1097/IOP.0b013e3181bd4341</pub-id>
          <pub-id pub-id-type="pmid">20523258</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
